Looks like the negative response to the earnings report was explained with the dilution that followed. There are always some that know in advance. Glad I got out when I started to see the negative reaction. May watch for possible reentry when the price is right, have to consider 202 million shares outstanding though in the valuation analysis.
(0)
(0)
Innovus Pharmaceuticals Inc. (INNV) Stock Research Links